Significantly Higher Procalcitonin Levels Could Differentiate Gram-negative Sepsis from Gram-positive and Fungal Sepsis

Overview

Journal Clin Exp Med

Specialty General Medicine

Date 2012 May 31

PMID 22644264

Citations 49

Authors

Helena Brodska

Karin Malickova

Vaclava Adamkova

Hana Benakova

Marketa Markova Stastna

Tomas Zima

Affiliations

Soon will be listed here.

Abstract

Procalcitonin (PCT) levels can distinguish between infectious and non-infectious systemic inflammatory response. However, there are some differences between Gram-negative (G-), Gram-positive (G+), and fungal bloodstream infections, particularly in different cytokine profiles, severity and mortality. The aim of current study was to examine whether PCT levels can serve as a distinguishing mark between G+, G-, and fungal sepsis as well. One hundred and sixty-six septic patients with positive blood cultures were examined on C-reactive protein (CRP) and PCT on the same date of blood culture evaluation. The median (interquartile range, IQR) of CRP and PCT in G+, G-, and fungal cohorts and comparison of measured values between groups were made using the Kruskal-Wallis test with subsequent Bonferroni's corrections, with p < 0.05. In 83/166 (50 %) of blood cultures, G+ microbes, 78/166 (47 %) G- rods, and 5/166 (3 %) fungi were detected. PCT concentrations (ng/ml) were significantly higher in G- compared to other cohorts: 8.90 (1.88; 32.60) in G-, 0.73 (0.22; 3.40) in G+, and 0.58 (0.35; 0.73) in fungi (p < 0.00001). CRP concentrations did not differ significantly in groups. Significantly higher PCT levels could differentiate G- sepsis from G+ and fungemia. In contrast to CRP, PCT is a good discriminative biomarker in different bloodstream infections.

Citing Articles

Exploring the clinical value of procalcitonin, c-reactive protein, white blood cell count, and neutrophil-to-lymphocyte ratio in the early diagnosis of bloodstream infections in children.

Li Y, Li M, Lin C, Tang W, Tang Q, Cheng F BMC Pediatr. 2025; 25(1):62.

PMID: 39856637 PMC: 11760693. DOI: 10.1186/s12887-025-05402-4.

Accuracy of procalcitonin for diagnosing sepsis in adult patients admitted to the emergency department: a systematic review and meta-analysis.

Zaki H, Bensliman S, Bashir K, Iftikhar H, Fayed M, Salem W Syst Rev. 2024; 13(1):37.

PMID: 38254218 PMC: 10802075. DOI: 10.1186/s13643-023-02432-w.

The Clinical Performance of Cell Population Data for Diagnosis of Bloodstream Infection in Cancer Patients.

Aoki M, Watanabe N, Taji Y, Ebihara Y Cureus. 2024; 15(12):e50857.

PMID: 38249249 PMC: 10798876. DOI: 10.7759/cureus.50857.

Case-Control Study: Endogenous Procalcitonin and Protein Carbonylated Content as a Potential Biomarker of Subclinical Mastitis in Dairy Cows.

Sala G, Orsetti C, Meucci V, De Marchi L, Sgorbini M, Bonelli F Vet Sci. 2023; 10(12).

PMID: 38133221 PMC: 10747190. DOI: 10.3390/vetsci10120670.

Machine learning model for the prediction of gram-positive and gram-negative bacterial bloodstream infection based on routine laboratory parameters.

Zhang F, Wang H, Liu L, Su T, Ji B BMC Infect Dis. 2023; 23(1):675.

PMID: 37817106 PMC: 10566101. DOI: 10.1186/s12879-023-08602-4.

References

Montagna M, Coretti C, Caggiano G . Procalcitonin: a possible marker of invasive fungal infection in high risk patients?. J Prev Med Hyg. 2011; 52(1):38-9. View

Brunkhorst F, Wegscheider K, Forycki Z, Brunkhorst R . Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med. 2008; 26 Suppl 2:S148-52. DOI: 10.1007/BF02900728. View

Levy M, Fink M, Marshall J, Abraham E, Angus D, Cook D . 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003; 31(4):1250-6. DOI: 10.1097/01.CCM.0000050454.01978.3B. View

Feezor R, Oberholzer C, Baker H, Novick D, Rubinstein M, Moldawer L . Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria. Infect Immun. 2003; 71(10):5803-13. PMC: 201043. DOI: 10.1128/IAI.71.10.5803-5813.2003. View

Pierrakos C, Vincent J . Sepsis biomarkers: a review. Crit Care. 2010; 14(1):R15. PMC: 2875530. DOI: 10.1186/cc8872. View

Vincent J, Sakr Y, Sprung C, Ranieri V, Reinhart K, Gerlach H . Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006; 34(2):344-53. DOI: 10.1097/01.ccm.0000194725.48928.3a. View

Vincent J, Donadello K, Schmit X . Biomarkers in the critically ill patient: C-reactive protein. Crit Care Clin. 2011; 27(2):241-51. DOI: 10.1016/j.ccc.2010.12.010. View

Gao H, Evans T, Finney S . Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?. Crit Care. 2008; 12(3):213. PMC: 2481435. DOI: 10.1186/cc6862. View

Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue R . Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?. Ann Rheum Dis. 2003; 62(4):337-40. PMC: 1754509. DOI: 10.1136/ard.62.4.337. View

10.

. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20(6):864-74. View

11.

Reinhart K, Meisner M . Biomarkers in the critically ill patient: procalcitonin. Crit Care Clin. 2011; 27(2):253-63. DOI: 10.1016/j.ccc.2011.01.002. View

12.

Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y . Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care. 2010; 14(2):R27. PMC: 2887127. DOI: 10.1186/cc8898. View

13.

Mohamed M, Cunningham-Rundles S, Dean C, Hammad T, Nesin M . Levels of pro-inflammatory cytokines produced from cord blood in-vitro are pathogen dependent and increased in comparison to adult controls. Cytokine. 2007; 39(3):171-7. DOI: 10.1016/j.cyto.2007.07.004. View

14.

Bjerre A, Brusletto B, Hoiby E, Kierulf P, Brandtzaeg P . Plasma interferon-gamma and interleukin-10 concentrations in systemic meningococcal disease compared with severe systemic Gram-positive septic shock. Crit Care Med. 2004; 32(2):433-8. DOI: 10.1097/01.CCM.0000104950.52577.97. View

15.

Charles P, Ladoire S, Aho S, Quenot J, Doise J, Prin S . Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis. 2008; 8:38. PMC: 2289831. DOI: 10.1186/1471-2334-8-38. View

16.

Reinhart K, Meisner M, Brunkhorst F . Markers for sepsis diagnosis: what is useful?. Crit Care Clin. 2006; 22(3):503-19, ix-x. DOI: 10.1016/j.ccc.2006.03.003. View

17.

Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent J . Procalcitonin levels in surgical patients at risk of candidemia. J Infect. 2010; 60(6):425-30. DOI: 10.1016/j.jinf.2010.03.003. View

18.

Simon L, Gauvin F, Amre D, Saint-Louis P, Lacroix J . Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004; 39(2):206-17. DOI: 10.1086/421997. View